{
    "title": "Gilead earnings beat Street estimates, writedown taken on cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10765169/Gilead-earnings-beat-Street-estimates-writedown-taken-cancer-drug.html",
    "date": "2022-04-28",
    "keywords": [
        "company",
        "cancer",
        "drug",
        "share",
        "beasley",
        "firstquarter",
        "revenue",
        "veklury",
        "value",
        "trial",
        "year",
        "analyst",
        "street",
        "gilead",
        "research",
        "development",
        "dickinson",
        "breast",
        "thursday",
        "biktarvy",
        "loss",
        "acquisition",
        "biotech",
        "estimate",
        "refinitiv",
        "quarter",
        "income",
        "charge",
        "officer",
        "conference",
        "call",
        "view",
        "march",
        "goal",
        "tumor",
        "growth",
        "form",
        "study",
        "accounting",
        "change",
        "likelihood",
        "launch",
        "use",
        "possibility",
        "market",
        "capital",
        "seigerman",
        "note",
        "companys",
        "trodelvy",
        "type",
        "bladder",
        "covid19",
        "treatment",
        "remdesivir",
        "brand",
        "name",
        "product",
        "percentage",
        "point",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}